Skip to Main Content

Author Details

Hae-Yun Jung
College of Life Science, CHA University
2003
28
15
PMIDPaper TitleJournal TitlePublished Year
36950218ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer.Oncoimmunology2023
37580389Author Correction: Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation.Nat Cell Biol2023
36950218ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer.Oncoimmunology2023
36028281Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy.J Immunother Cancer2022
35409069ELK3 Controls Gastric Cancer Cell Migration and Invasion by Regulating ECM Remodeling-Related Genes.Int J Mol Sci2022
35858708ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics.J Immunother Cancer2022
32414208Functional Link between miR-200a and ELK3 Regulates the Metastatic Nature of Breast Cancer.Cancers (Basel)2020
33290037Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy.ACS Appl Mater Interfaces2020
32574556Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex.Dev Cell2020
32762722PDX models of human lung squamous cell carcinoma: consideration of factors in preclinical and co-clinical applications.J Transl Med2020
30804505Apical-basal polarity inhibits epithelial-mesenchymal transition and tumour metastasis by PAR-complex-mediated SNAI1 degradation.Nat Cell Biol2019
30374053TMEM9 promotes intestinal tumorigenesis through vacuolar-ATPase-activated Wnt/β-catenin signalling.Nat Cell Biol2018
25107915Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis.Clin Cancer Res2015
25575073Unraveling the TWIST between EMT and cancer stemness.Cell Stem Cell2015
22237146Can serum be used for analyzing the EGFR mutation status in patients with advanced non-small cell lung cancer?Am J Clin Oncol2013
24055345PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation.Mol Cell2013
23864847RASSF1A Suppresses Cell Migration through Inactivation of HDAC6 and Increase of Acetylated α-Tubulin.Cancer Res Treat2013
23612978HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.J Biol Chem2013
23362280Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation.J Biol Chem2013
23341789The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer.Cancer Res Treat2012
21811427An association study of polymorphisms in JAK3 gene with lung cancer in the Korean population.Cancer Res Treat2011
20944145A study of RET proto-oncogene polymorphisms in association with lung cancer risk in the Korean population.Anticancer Res2010
19156899Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.Cancer2009
18363031Association study of TP53 polymorphisms with lung cancer in a Korean population.J Hum Genet2008
18374229Combination of PTEN and gamma-ionizing radiation enhances cell death and G(2)/M arrest through regulation of AKT activity and p21 induction in non-small-cell lung cancer cells.Int J Radiat Oncol Biol Phys2008
17609851Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean population.J Hum Genet2007
15715961CDK2/4 regulate retinoic acid-induced G1 arrest in hepatocellular carcinoma cells.Hepatol Res2005
26680915Correlation between Retinoic Acid Sensitivity and IGFBP-3, AFP Protein Expression in Hepatoma Cell Lines.Cancer Res Treat2003
  • 1 - 28 of 28

Recommended Authors

Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 0
UPMC Hillman Cancer Center
Career Start Year 2012
Number of shared co-authors 0
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
National Taiwan University College of Medicine
Career Start Year 2008
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Central South University
Career Start Year 2006
Number of shared co-authors 0
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
Peking University Cancer Hospital & Institute
Career Start Year 2002
Number of shared co-authors 0
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 1
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 1
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 0
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 2
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
The First Hospital and College of Basic Medical Sciences, China Medical University
Career Start Year 1990
Number of shared co-authors 0
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 0

Collaborators

University of California San Diego
Co-authored papers 5
Moores Cancer Center, University of California
Co-authored papers 4
McLean Hospital and Program in Neuroscience, Harvard Medical School
Co-authored papers 2
Co-authored papers 2
University of California
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
University of California
Co-authored papers 1
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
Rice University, University of California San Diego
Co-authored papers 1
University of Texas MD Anderson Cancer Center
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Busan Paik Hospital, Inje University
Co-authored papers 1
University of California
Co-authored papers 1
The University of Texas MD Anderson Cancer Center
Co-authored papers 1